Use of artificial intelligence chatbots in clinical management of immune-related adverse events.

Journal: Journal for immunotherapy of cancer
PMID:

Abstract

BACKGROUND: Artificial intelligence (AI) chatbots have become a major source of general and medical information, though their accuracy and completeness are still being assessed. Their utility to answer questions surrounding immune-related adverse events (irAEs), common and potentially dangerous toxicities from cancer immunotherapy, are not well defined.

Authors

  • Hannah Burnette
    Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Aliyah Pabani
    Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Mitchell S von Itzstein
    Harold C Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Benjamin Switzer
    Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Run Fan
    Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Fei Ye
    School of information science and technology, Southwest Jiaotong University, ChengDu, China.
  • Igor Puzanov
    Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Jarushka Naidoo
    RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Paolo A Ascierto
    Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy.
  • David E Gerber
    Harold C Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Marc S Ernstoff
    ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy and Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
  • Douglas B Johnson
    Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.